Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Susan Fineberg
The ZNF217 Biomarker Predicts Low- And High-Risk Oncotype DX® Recurrence Score in ER-Positive Invasive Breast Cancers
Frontiers in Pharmacology
Pharmacology
High Expression of Class III Β-Tubulin Predicts Good Response to Neoadjuvant Taxane and Doxorubicin/Cyclophosphamide-Based Chemotherapy in Estrogen Receptor–Negative Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Related publications
Oncotype Dx Recurrence Score Among BRCA1/2 Germline Mutation Carriers With Hormone Receptors Positive Breast Cancer
International Journal of Cancer
Cancer Research
Oncology
Treatment Decisions in Estrogen Receptor-Positive Early Breast Cancer Patients With Intermediate Oncotype DX Recurrence Score Results
SpringerPlus
Multidisciplinary
Oncotype DX Breast Cancer Recurrence Score Resists Inter-Assay Reproducibility With RT2-Profiler Multiplex RT-PCR
Scientific Reports
Multidisciplinary
The Impact of Oncotype DX® Recurrence Score of Paraffin-Embedded Core Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in Women With Breast Cancer
Breast Disease
Medicine
Cancer Research
Oncology
Evaluation and Correlation of Risk Recurrence in Early Breast Cancer Assessed by Oncotype DX®, Clinicopathological Markers and Tumor Cell Dissemination in the Blood and Bone Marrow
Molecular and Clinical Oncology
Cancer Research
Oncology
Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age
Advances in Therapy
Medicine
Pharmacology
A Weighted Genetic Risk Score Predicts Surgical Recurrence Independent of High-Risk Clinical Features in Dupuytren’s Disease
Plastic and Reconstructive Surgery
Surgery
Oncotype Dx® in the Sistema Único De Saúde Do Brasil (Sus): Result of 125 Cases
Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
